Beruflich Dokumente
Kultur Dokumente
I.
PREPARATION,
BY W. J. POLGLASE,
(From
ON HUMAN
PURITY,
EMIL
AND
GLYCOGEN
AVERAGE
L. SMITH,
CHAIN
AND FRANK
the Laboratory
for the Study
of Hereditary
and Metabolic
Departments
of Biological
Chemistry
and Medicine,
University
of Medicine,
Salt Lake City, Utah)
(Received
for
publication,
February
LENGTH*
H. TYLER
Disorders,
and
of Utah College
the
5, 1952)
* This investigation
was aided by research
grants
from the National
Institutes
Health,
United
States Public
Health
Service.
1 W. Krivit,
W. J. Polglase,
F. D. Gunn,
and F. H. Tyler,
in preparation.
97
of
98
HUMAN
GLYCOGEK.
W.
J.
POLGLASE,
E.
L.
SMITH,
AND
F.
H.
TYLER
99
* The boiling
point of water
is 94 at the altitude
of this laboratory.
3 It was usually
necessary
to add a trace of electrolyte
(lithium
chloride)
coagulation
at this point.
to induce
100
HUMAN
GLYCOGEN.
solution.
This solvent was chosen for two reasons.
First, human liver
glycogen gives solutions of high opalescence, and transmission
of light in
molar saline is somewhat better.
Nevertheless,
in most cases the maximum concentration
of liver glycogen which could be used in a 1 dm.
polarimeter tube was 1 per cent. Second, aqueous molar sodium chloride
has been used in most of the published ultracentrifuge
studies on glycogen
TABLE
Yield
Liver,
Muscle,
Heart
normal,
Purity
of Human
I
Glycogen
Samples
Yield
a. (P. F.).
_.
(J. H. W.).
b. (J. K.)
_.
glycogen
storage,
b. (N. D.)
1.8
0.17
2.2
35
it (P. N.)...::
2.1
0.29
normal,
a. (P. F.)
125
0.076
b. (B.K.)
5.7
0.027
a.
A..
4.4 : 0.31
I
I
B..
1.9
0.12
I
I
I
25.
2.5
0.21
b. (P. N.)
0.50 Trace
a. (N. D.).
.I 1.2 ~ 0.083
I
0.1
ysist
+192
5+48.5
9.1 $202
6.3 f198
13.8
+192
0.06+191
0.5 +2OO
0.7 +isS
8.9
+191
7.1 f192
6.4 +200
8.4 +199
f
f
f
f
f
f
f
f
f
f
5.
5f49.9
2+49.7
2
2
2
2
2+49.1
2f52.5100
2
rt
2,
2.5
+191
92.4
95.0
94.7
93.5
* Determined
at a concentration
of 1 per cent in 1 M sodium
chloride.
t Calculated
on basis of liberated
n-glucose.
$ Calculated
from rotation
of hydrolyzed
glycogen
as compared
to equilibrium
rotation
of n-glucose
(+52.59).
$ a., autopsy;
b., biopsy.
Tissue
was permitted
to stand
at room temperature
(about
23) for 17 hours before
isolation
of glycogen.
Tissue
and
W.
J.
POLGLASE,
E.
L.
SMITH,
AND
F.
H.
TYLER
101
102
HUMAN
QLYCOGEN.
W.
J.
POLQLASE,
E.
L.
SMITH,
AND
F.
II.
103
TYLER
Source
Method
length
T-
-5 hrs.
(J. H. W.)
.
.
Heavy fraction (P. F.) (2).
.
(2) . . . . . . . . .
.
Light
(N. D.) . . . . . . . . . . . . .
.
Autopsy heavy fraction (N. D.) (2). . .
<
light
I
(2).
.
Rabbit liver...............................,
Human muscle, normal
Autopsy (P. F.).
. . . .. .... ... . .. .
Biopsy (G. G.). . . .
. . . .. . .
Human muscle, glycogen storage
Biopsy (N. D.). . . .
.. .
.
The numbers in parentheses
18.0
18.0
18.0
14.0
14.0
refer to bibliographic
Method
B (11)
24 hrs.
48 hrs.
12 hrs.
13.5
14.0
13.5
15.0
12.5
13.0
12.5
14.0
11.5
17.0
13.5
9.5
11.0
10.5
14.5
12.5
8.5
10.5
9.5
14.0
7.0
12.0
11.5
14.5
14.5
13.0
citations.
arations from the liver of N. D., which gave values of 9.5 to 11, differed
significantly from the results obtained on other samples, which varied from
13 to 15. The fractions separated on the basis of particle weight (2) from
the liver of P. F., a normal individual, did not show significant differences
in chain length.
Likewise, the light and heavy fractions from the liver of
N. D. were essentially identical and with a shorter average chain length.
Determinations by Method R also show the difference in chain length for
the glycogen samplesof the two individuals, although the absolute values
are higher than those obtained by Method A.
It is of interest that the liver glycogen of the patient (P. N.) with von
Gierkes diseasehad a normal chain length.
Chain
104
HUMAN
GLYCOGEN.
An interpretation
of the significance of these data for human glycogen
storage diseases cannot be presented with the limited data available at this
time. The important observation is that glycogen disorders may be accompanied by abnormal glycogen structures.
These abnormalities
may lx
associated with chain length, as in the case of N. I)., or, as noted in the
following paper (2), with particle size.
SUMMARY
BIBLIOGRAPHY
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Mason,
H. H., and Andersen,
D. H., Am. J. Dis. Child.,
61, 795 (1941).
Polglase,
W. J., Brown,
D. M., and Smith,
E. L., J. Biol. Chem., 199, 105 (1952).
Tyler,
F. H., Witten,
T. A., and Stephens,
F. E., Am. J. Med., 6, 391 (1949).
Bell, D. J., and Young,
F. G., Biochem.
J., 28,882
(1934).
Bell, D. J., Biol. Rev. Cambridge
Phil.
Sot., 23, 256 (1948).
Good,
C. H., Kramer,
H., and Somogyi,
M., J. Biol. Chem., 100, 485 (1933).
Haworth,
W. N., and Percival,
E. G. U., J. Chem. Sot., 2277 (1932).
Haworth,
W. N., Hirst,
E. L., and Smith,
F., J. Chem. Sot., 1914 (1939).
Halsall,
T. G., Hirst,
E. L., and Jones, J. K. N., J. Chem. Sot., 1399 (1947).
Cori, G. T., and Lamer,
J., J. Biol. Chem.,
188, 17 (1951).
Schlamowitz,
M., J. Biol. Chem., 188, 145 (1951).
Abdel-Akher,
M., and Smit,h, F., J. Am. Chem. Sot., 73, 994 (1951).
Potter,
A. L., and Hassid,
W. Z., J. Am. Chem. Sot., 70.3488
(1948).
ARTICLE:
STUDIES ON HUMAN GLYCOGEN: I.
PREPARATION, PURITY, AND
AVERAGE CHAIN LENGTH